Awarded

Sumatriptan - DAK-G, KKH (ATC: N02CC01)

Name: Sumatriptan - DAK-G, KKH (ATC: N02CC01)
Creator: Techniker Krankenkasse
Published: 2026-10-26
License: https://ted.europa.eu/en/simap/legal-notice

Original language: German

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Buyer: Techniker Krankenkasse
Winners: 1 A Pharma GmbH, betapharm Arzneimittel GmbH, Hexal AG, PUREN Pharma GmbH & Co. KG
Contract value: no value published
Bids received: 8
Published: 26 Oct 2026
Awarded: 5 Oct 2026
Contract start: 1 Apr 2027
Contract end: 31 Mar 2029stated
Sector: Medical equipment and pharmaceuticals
Region: Hamburg
Source: Original notice on TED (746346-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
Siehe im Feld "Allgemeine Informationen"	Techniker Krankenkasse	Siehe im Feld "Allgemeine Informationen"	—	27 Oct 2026
Sektoraler Identity Provider (IDP) - Angebotsphase	Techniker Krankenkasse	Research Industrial Systems Engineering (RISE) Forschungs-, Entwicklungs- und Großprojektberatung GmbH	—	27 Oct 2026
Valsartan, Amlodipin und HCT - DAK-G, KKH (ATC: C09DX01)	Techniker Krankenkasse	Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH, MACLEODS PHARMA ESPAÑA S.L.U	—	26 Oct 2026
Valsartan, Amlodipin und HCT - Barmer (ATC: C09DX01)	Techniker Krankenkasse	Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH, MACLEODS PHARMA ESPAÑA S.L.U	—	26 Oct 2026
Valsartan, Amlodipin und HCT - TK, hkk, HEK (ATC: C09DX01)	Techniker Krankenkasse	Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH, MACLEODS PHARMA ESPAÑA S.L.U	—	26 Oct 2026
Testosteron undecanoat - DAK-G, KKH (ATC: G03BA03)	Techniker Krankenkasse	AbZ-Pharma GmbH, Basics GmbH, Medical Valley Invest AB +2 more	—	26 Oct 2026